Eco Animal Health Dividends - EAH

Eco Animal Health Dividends - EAH

Best deals to access real time data!
Monthly Subscription
for only
Level 2 Basic
Monthly Subscription
for only
UK/US Silver
Monthly Subscription
for only
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Eco Animal Health Group Plc EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change Price Change % Stock Price Last Trade
4.00 1.06% 380.00 10:06:31
Open Price Low Price High Price Close Price Previous Close
370.00 370.00 380.00 380.00 376.00
more quote information »
Industry Sector

Eco Animal Health EAH Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount

Top Dividend Posts

igoe104: I see the naked trader is looking to buy these, that's two shares in two weeks that I hold he's written about. Another I was waiting to buy after the online seminar was Eco Animal Healthcare (EAH). I tend to hesitate to buy shares on a high rating like this one as any disappointment can lead to a big drop. But the animal healthcare market is just getting bigger and bigger- this one makes and develops animal healthcare products across the globe. According to management it is trading well above expectations and the real excitement coming from China. It is doing especially well there with massive demand for its flagship product. So even given its high rating there could be a lot more to come and results in June I suspect will be really good. Brokers on research-tree reckon it is the top pick in the vet pharma space on both valuation and growth considerations. (If you want a 20c discount on the broker notes go to set up free account and click upgrade then put nakedtrader into the promo code).
igoe104: Alittle bit of ASF should benefit EAH, because Chinese farmers are going to be worried into buying more quality vaccines rather than the cheaper Chinese alternatives. As long as it doesn't spread across the country, which it hasn't so far this year EAH should benefit.
boonkoh: European Commission this week released their latest report on pork exports from EU to China. Was expected to fall - 10% in 2021 vs 2020 but now expected to only fall - 2% because ASF is dampening supply in China.Not good news for EAH then, if the rebuilding of herds is slowing down or stopping or even going into reverse. Seems like ASF is being seen as being persistent in China herds this year.
igoe104: Most probably folks cashing shares in from share accounts so they can switch the cash into a isa, and triggering off a bunch of stop losses. These strange moves happen this time of year. We know full year results are going to be outstanding, and if the dividend is reinstated these should move up significantly.
cerrito: I am finding it difficult to get a handle on how important the ASF outbreak is for EAH. The Rabobank report is only available for their clients. The FT had a good story and reports that future hog prices on the Dalian exchange have gone up which would make one think that producers will give their piglets more TLC. I see that ANP have made the same comment as EAH - namely that the emergence of bigger more modern farms in China makes it easier to do business.
porky20: The new variants of ASF in China are leading to low level respiratory disease which should benefit EAH sales.
cerrito: Yes v good update and good that US doing well. It would be good to get an insight as to who benefits from the great business currently in China ie the JV or the EAH companies ex China on the basis that they are supplying the China JV. Incidentally I took them up on their offer to ask questions before the AGM but have received no reply. Any of you have better luck?
cerrito: I have been going through both the recently published AR and the interims to see if I should increase my holding. I think I will stay where I am for now but would appreciate comments from you all as to where I have misunderstood. One big reason for me not buying more is I am having difficulty in understanding the company and one reason for that is that they do not appear to bother with IR for their retail investors. I take the point that it appears unlikely that they will need to do a fund raise in the immediate future and that those holding over 3% have a combined 65% share holding-ie retail investors are less important than in some other companies. That said they could have been more welcoming in their AGM like for example CWR and ITM or at the very least have done an Investor Meets Company type operation. I should add that the Finances seem better managed than in the past. It was surprising to read n page 126 of the AR that over an extended period an ex Director had helped herself to £300k+ without it being picked by internal or external auditors. Also, a bit disorientating to see that in the two years to March 2020 they paid out £18m in dividends and then we read in the latest interims they had to cut back on their R&D programme as they had insufficient cash. Suggests that perhaps a,lack, in the past, of long term strategic financial planning. What is welcome that there is now more transparency as to where the cash is i.e., China or non China than we seem to have had in the past. It is of course great that consolidated net cash grew from £9.8m at end March 2020 to £12.9m at end September 2020. However, that was due to cash balances of the Chinese company growing from £5.3m to £9.7m and cash balances ex China decreasing from £4.5m to £3.2m. The interims recognize that this cash balance in China-51% owned by EAH- gets transferred by dividends, as one would expect. It would be interesting to know when the next dividend will be paid. My reading of Pages 105/7 of the AR is that EAH would have got £1.6m and £0.97m in FY 2018/19 and 19/20 respectively…but please check that. Let’s hope that this next dividend is going to be higher. My reading of page 106 of the AR which shows a decline in 2020 over 2019 in plant and equipment of the Chinese JV is that the new factory in China is not owned by the JV but rather one assumes by a 100% owned EAH company…is that how you understand it? Begs the question to me is how they realize their factory investment in pounds sterling. All in all, I can well understand why they are not paying a dividend and I go on the basis that any dividend for this FY will be token. I note that the overdraft facility reported on Page 115 of the AR was new. I admit I am surprised that this facility repayable on demand is secured with what would appear to be a highish margin of 1.8%. All seems rather odd to me and suggests that the bank not all that comfortable. Page 116 tells us that the weighted average incremental borrowing rate for lease finance is a, to me, high 7.1%, I was interested to read page 87 of the AR with its good table of in which geographic markets they make their Ebitda. Interesting to see that in the year to 3/20 S and SE Asia far more profitable than China and Japan as regards adjusted ebitda to revenue from external customers and total assets but guess the picture will be different this FY
cerrito: Good stuff in the interims which is no surprise given the TU's and what ANP and Genus have told us. . That said my hand was hovering over the buy button till I saw the news of no dividend. Good that they spelt out the proportion of cash held in China. I note their comment on dividends from China and also the dividends due under current liabilities which I assume are the dividends due to the Chinese partner. Also note that for reasons not explained that the cash flow statement tells us they increased borrowing by £2m.
1aconic: Yeah, the websites are awful! I just assume that most selling is through distribution channels and not so much ad hoc direct customer chasing - from what I can gather that's the case with a lot of vetinary medicines but not entirely sure over everything EAH does. There was another big round of selling (an almost identical 725,000 equating to over 1%) in late Sept. My thinking on that is one of the institutions is reducing because of the Germany ASF outbreak. Think it might be just part on an institution being cautious and don't want to be caught by a major problem they have to explain to investment boards and fund holders. They'd rather sell now and buy later at a much higher price when it's de-risked (e.g. a vaccine announced) a bit rather than be caught with their pants down. I personally think it's a little short sighted as EAH seems to be holding up well in terms of revenue despite it's main market already having been absolutely decimated. Would be interested to hear other people's views on that too.
ADVFN Advertorial
Your Recent History
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210422 18:05:08